Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 30, 2020

SELL
$9.57 - $27.05 $7.38 Million - $20.9 Million
-771,427 Closed
0 $0
Q2 2020

Aug 11, 2020

SELL
$7.14 - $31.69 $6.19 Million - $27.5 Million
-866,499 Reduced 52.9%
771,427 $20.8 Million
Q1 2020

May 14, 2020

SELL
$2.98 - $14.09 $8.78 Million - $41.5 Million
-2,947,040 Reduced 64.28%
1,637,926 $12.2 Million
Q4 2019

Jan 31, 2020

BUY
$1.97 - $3.72 $713,683 - $1.35 Million
362,276 Added 8.58%
4,584,966 $15.1 Million
Q3 2019

Nov 12, 2019

BUY
$2.05 - $3.02 $548,729 - $808,372
267,673 Added 6.77%
4,222,690 $8.66 Million
Q2 2019

Jul 30, 2019

BUY
$2.29 - $4.1 $2.35 Million - $4.2 Million
1,025,420 Added 35.0%
3,955,017 $11.6 Million
Q1 2019

May 13, 2019

BUY
$3.34 - $5.1 $3.49 Million - $5.32 Million
1,043,956 Added 55.36%
2,929,597 $10.9 Million
Q4 2018

Feb 01, 2019

SELL
$3.89 - $6.11 $122,262 - $192,037
-31,430 Reduced 1.64%
1,885,641 $7.54 Million
Q3 2018

Nov 07, 2018

BUY
$3.92 - $5.58 $2.83 Million - $4.03 Million
722,414 Added 60.47%
1,917,071 $10.7 Million
Q2 2018

Aug 07, 2018

BUY
$3.88 - $5.16 $2.06 Million - $2.74 Million
530,247 Added 79.81%
1,194,657 $4.68 Million
Q1 2018

May 14, 2018

BUY
$4.05 - $5.69 $1.53 Million - $2.15 Million
378,133 Added 132.09%
664,410 $3.13 Million
Q4 2017

Feb 12, 2018

BUY
$4.13 - $6.68 $590,152 - $954,531
142,894 Added 99.66%
286,277 $1.18 Million
Q3 2017

Nov 09, 2017

BUY
$5.36 - $6.37 $415,303 - $493,560
77,482 Added 117.57%
143,383 $909,000
Q2 2017

Aug 11, 2017

BUY
N/A
29,128 Added 79.21%
65,901 $517,000
Q1 2017

May 15, 2017

BUY
N/A
5,547 Added 17.76%
36,773 $243,000
Q4 2016

Feb 13, 2017

BUY
N/A
31,226
31,226 $217,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $519M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.